Tradestie Institutional Equity Comparison Engine

DLX vs HHS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DLX Overall Edge

DLX Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Deluxe Corporation (DLX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DLX trades at 6.5x Forward P/E with 12.8% operating margin (+2.5% YoY revenue) versus HHS at 14.3x Forward P/E and -3.2% operating margin (-1.7% YoY). In options structure, DLX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner DLX
DLX 6.5x vs HHS 14.3x Fwd P/E
Growth & Margin Winner DLX
Op Margin 12.8% vs -3.2% ยท YoY +2.5% vs -1.7%
Momentum & Technical Winner DLX
1Y +32.3% vs +8.8% ยท 52W Pos 63% vs 69%
Options & Structure Winner DLX
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
DLX NYSE
Deluxe Corporation
Blankbooks, Looseleaf Binders & Bookbindg & Relatd Work
$27.05
+1.01% 1D
Market Cap $1.2B
1M Return +16.7%
1Y Return +32.34%
Forward P/E 6.5x
Unified AI Score
31.4 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
1M Return -10.49%
1Y Return +8.78%
Forward P/E 14.3x
Unified AI Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DLX +32.34% HHS +8.78% Spread: +2.4 pp (HHS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DLX TTM Op. Margin: 12.8% HHS TTM Op. Margin: -3.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DLX vs HHS. Trailing 12-month operating profitability (DLX 12.8% vs HHS -3.2%) and valuation multiples (DLX 6.5x vs HHS 14.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DLX (6) vs HHS (4)
Institutional Metric DLX HHS Criterion Row Winner
Market Capitalization Scale $1.2B $30.0M Larger Scale DLX
Trailing P/E Ratio Valuation 15.5x 14.3x Lower Multiple HHS
Forward P/E Ratio Valuation 6.5x 14.3x Lower Multiple DLX
Revenue Growth (YoY) Growth +2.5% -1.7% Higher Growth DLX
Operating Margin (TTM) Profitability 12.8% -3.2% Higher Margin DLX
Net Profit Margin Profitability 3.8% -3.7% Higher Margin DLX
Return on Equity (ROE) Capital Efficiency 11.6% -30.4% Higher ROE DLX
52-Week Range Position Momentum 63% ($19โ€“$32) 69% ($2โ€“$5) Stronger Trend HHS
Beta / 30D Volatility Risk Regime -0.45ฮฒ ยท 75% Vol 0.49ฮฒ ยท 46% Vol Lower Realized Risk HHS
Unified Institutional Score Composite Signal 31.4 / 100 (SELL) 61.8 / 100 (BUY) Higher Composite HHS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DLX vs HHS Buy Guide
DLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live DLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HHS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HHS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DLX nor HHS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.